Our new brief review on Resistant HTN is out today in JAMA Internal Medicine John Giacona, PhD, PA-C🫀 Weerapat Kositanurit UTSW Heart jamanetwork.com/journals/jamai…

We hope, you‘ll like it and find it useful. First time on stage during #ECE2024 on Monday, then in Boston during #endo2024. Join us for discussion! Niki Karavitaki Irina Bancos Alessandro Prete Endocrine Society European Society of Endocrinology (ESE)

European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency academic.oup.com/ejendo/article… For all specialists caring for patients on glucocorticoids. Honoured to contribute! @IMSR_UoB Birmingham Health Partners

In adults with congenital adrenal hyperplasia, crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist, lowered the mean glucocorticoid dose and decreased the mean androstenedione level. Full CAHtalyst trial results: nej.md/4aFpNVD #ASCO24

Game changer for patients with CAH!

Dynamic duo: Felix Beuschlein (European Society of Endocrinology (ESE) & Endocrine Society Transatlantic Alliance Award) & Wiebke Arlt (A5_AdrenalAlliance #IAM2024 Keith Parker Memorial Award) discuss salt, sugar & sex hormones in symposium honoring Felix’s Award for collaborative engagement across continents!

Progressive 11bHSD2 Insufficiency and Mineralocorticoid Receptor Activation as Kidney Function Declines - Amazing collaboration Santiago 🇨🇱-Boston 🇺🇸 René Baudrand B Anand Vaidya Andrew Newman Internacional Adrenal Meeting #IAM2024 A5_AdrenalAlliance Endocrine Society #Endo2024

Our meta-analysis found that in #LowReninHypertension, treatment with mineralocorticoid receptor antagonists lowered systolic BP to a greater extent compared to commonly used first-line antihypertensive agents. Hudson Institute Endocrine Society of Australia Hypertension Australia nature.com/articles/s4137…

Sharing some challenges (and solutions) in diagnosing and managing the spectrum of primary aldosteronism Hudson Institute Monash University School of Clinical Sciences Hypertension Australia Elisabeth Ng Endocrine Society of Australia Endocrine Society academic.oup.com/jes/article/do…

Important reading for ALL clinicians who prescribe glucocorticoids: avoid pitfalls and unnecessary consults, learn the basic pearls and advanced strategies for glucocorticoid management. Summary below, full guideline link here: academic.oup.com/ejendo/article…

This interactive feature describes a 66-year-old man who presented to the ED with 3 days of progressively worsening chest discomfort. Test your diagnostic and therapeutic skills: nej.md/4cZlEOb

Our paper with Weerapat Kositanurit John Giacona, PhD, PA-C🫀 Jordy Cohen, MD, MSCE Anand Vaidya Ann Marie Navar highlighting stagnant trends in screening of primary aldo in patients at risk is out in doi.org/10.1161/JAHA.1…

#Adrenal consult case Michigan Pathology with primary hyperaldosteronism - Aldosterone producing nodule + multiple aldosterone-producing micronodules. CYP11B2 IHC essential and one of the best IHC assays. #GoBlue

Following SST, 100% had decreased serum Ca with ~50% developed new-onset hypocalcemia. These acute reductions in bioavailable Ca are associated with lower post-SST aldosterone. Thank you Anand Vaidya Jen Brown & the team! academic.oup.com/ejendo/article…

Very interesting finding of a decrease in serum calcium with saline infusion... can this lead to lower aldosterone post-saline and an erroneous interpretation of the SST result??? A5_AdrenalAlliance PrimaryAldosteronismOrg Endocrine Society of Australia

PA screening rates among at-risk patients remain low despite guidelines. COVID-19 saw a plateau in screenings for resistant HTN or HTN with hypokalemia. #AHAJournals #ResearchLetter Weerapat Kositanurit John Giacona, PhD, PA-C🫀 Ann Marie Navar Anand Vaidya Jordy Cohen, MD, MSCE Wanpen Vongpatanasin ahajrnls.org/4dMKssP

Saline suppression testing-induced #hypocalcemia and implications for clinical interpretations by Wasita W. Parksook @anandvaidya17 et al EJE Volume 191, Issue 2, August 2024 Full paper 👉 doi.org/10.1093/ejendo… ESE Members free via 👉 my.ese-hormones.org #parathyroid

Still’s disease is an uncommon, systemic, autoinflammatory disease of uncertain cause. It is often misdiagnosed because of heterogeneous symptoms, including fever, rash, leukocytosis, and arthralgia. Learn more in the latest Interactive Medical Case: nej.md/3zmYR0n

We showed an association between markers of #PrimaryAldosteronism and left ventricular mass index in young, relatively healthy, adults RaineStudy. How early should we screen for aldosterone excess? More to research! Hudson Institute Hypertension Australia PrimaryAldosteronismOrg Endocrine Society of Australia